Can Shoppers Drugmart Win in a Tough Market?

Shoppers Drugmart is well-positioned, but the market remains challenging.

| More on:
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Shoppers Drugmart (TSX:SC) reported lackluster results last week, citing consumers who remain “value conscious and price competitive” according to CEO Dominic Pilla. As the closing date for the $12.4 billion acquisition of Shoppers by Loblaw (TSX:L) approaches, let’s look at some of the key takeaways that investors should keep in mind and digest.

Review of Q4 results

Sales increased 0.9% in the fourth quarter. Pharmacy sales accounted for 44.8% of total sales. Same-store sales growth in pharmacy declined 0.5%. Similar to Jean Coutu’s (TSX:PJC.A) experience, the company saw a decline in the value of pharmacy sales due to an increase in generic prescriptions. On a positive note, prescriptions filled increased 4.7%, and front-end same-store sales growth was a respectable 1.7%.

Operating margins declined 5.1% in the quarter due partly to promotional activity, as price points decreased and marketing expense increased. The company also experienced an increase in store costs in general, as wages and other expenses also increased.

Marketplace still very competitive

Promotional activity during the quarter remained high, as an increasingly competitive environment and increasingly price-sensitive consumers continue to take a toll on the company and retailers in general.

We have seen Target (NYSE:TGT) enter the Canadian market last year, and although it has been struggling, it represents another competitor that Shoppers has to deal with. This has intensified the competitive landscape, and Shoppers is not alone in feeling the effects. Jean Coutu is also feeling pressure, as the company’s most recent quarter saw overall same store sales growth declining 1.3%.  

Loblaw is also feeling the pinch of the consumer, which we saw in its third-quarter results, as profit declined a whopping 29% due to reduced margins. Loblaw’s acquisition of Shoppers Drugmart is expected to strengthen the competitive position of both companies in the marketplace.

The good news for Shoppers is the market share increases it is seeing. On the conference call, management said that the cosmetic business, for example, gained 50 basis points of market share and the food business saw a 30 basis point increase in market share.

Foolish bottom line

The marketplace remains challenging for Shoppers Drugmart, but it appears that Shoppers is very well positioned within the space. During the quarter, the company acquired five independent pharmacies, and they continue to generate good cash flow.  Pharmacy sales account for 44.8% of total sales, and over-the-counter and health products account for 17% of total sales, so we have approx. 57% of sales that are relatively economically insensitive.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no positions in any of the companies mentioned in this article.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »